Rapid Sterility Instrument
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
75F40126Q132933
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6640
Additional Details
Documents1
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued a combined synopsis/solicitation for the procurement of a Rapid Sterility Instrument. This opportunity, identified by procurement number 75F40126Q132933, is intended to support the FDA’s mission by acquiring advanced analytical laboratory equipment that enhances sterility testing capabilities. The procurement falls under NAICS code 334516, which pertains to Analytical Laboratory Instrument Manufacturing, and is further classified under Product Service Code 6640.
The scope of this solicitation encompasses the supply and potential installation of a Rapid Sterility Instrument at the FDA’s facility in Irvine, California. The primary objective is to obtain a state-of-the-art instrument that enables rapid and reliable sterility testing, thereby supporting the FDA’s regulatory and research functions. Contractors are expected to provide a solution that meets stringent analytical performance standards, ensuring accuracy, efficiency, and compliance with relevant laboratory protocols.
Key requirements and expected deliverables include the provision of a fully functional rapid sterility testing instrument, along with any necessary accessories, documentation, and user training as specified in the solicitation. The instrument must be suitable for use in a high-throughput laboratory environment and align with the FDA’s operational needs. While the detailed technical specifications and performance criteria are outlined in the attached solicitation document, interested vendors should be prepared to demonstrate their capability to deliver, install, and support the proposed equipment.
The contracting activity is managed by the FDA Office of Acquisition and Grant Services, a federal office responsible for overseeing procurement activities within the agency. The primary point of contact for this solicitation is Warren Dutter, who can be reached via email at [email protected] or by phone at 301-796-2486. The place of performance for this contract is Irvine, California, United States.
This procurement is being conducted as a combined synopsis/solicitation, streamlining the acquisition process and allowing for a more efficient evaluation of vendor responses. The notice does not specify any set-aside requirements or special considerations; interested parties should review the attached solicitation for any additional instructions or eligibility criteria.
The solicitation remains active, with the due date for receipt of quotes extended to 1:00 PM on April 9, 2026. Contractors are encouraged to review the full solicitation document, available via the provided SAM.gov link, to ensure a comprehensive understanding of the requirements and submission procedures. This opportunity represents a significant engagement for vendors specializing in analytical laboratory instruments, particularly those with experience in rapid sterility testing solutions for federal agencies.